Home / About CBD
Cannabidiol (CBD) is a naturally occurring compound first discovered in hemp and flax oil. It matches some human neurotransmitters involved in lots of bodily processes including pain, mood, memory and cancer control, so is fast becoming a standard addition in markets of medicinal and health products.
Consequently, CBD is proving to be a leap forward in wellness, showing therapeutic applications in such a variety of facets of human health that it is being suggested that our dietary deficit of cannabinoids during prohibition years is a contributing factor to our illness burden.
CBD is not to be confused with the compounds in cannabis plants which produce the primary psychoactive effects associated with a cannabis high. CBD is virtually undetectable when consumed by humans even in larger quantities. It is valued for therapeutic purposes and for its very low side effect profile.
Global supply of CBD cannot currently meet the enormous demand. Demand is increasing from both a consumer product level as it finds applications in cosmetic and natural wellness industry, as well growing commercial demand from pharmaceutical industry.
Wholesale prices start at the USD$5,000 per kg market. Large industrial buyers pay up to USD$7,000 for pharmaceutical grade.
Our patented method of producing generic cannabidiol using organic chemistry and proprietary biosynthesis technology means larger quantities can be produced faster, cheaper, and independently of seasonal variations, with less environmental impact.
Our target CBD production cost in USD$200 per kg, and first factory has peak output capacity of 360,000kg per year.
Psilocybin mushrooms have been used by indigenous cultures for millennia for their therapeutic and mystical benefits. Western cultures have been denied this natural gift due to fear and taboo. Now, science has rediscovered its potential, and modern man is gaining access to this ancient tool.
Research is showing microdosing LSD (taking tiny amounts) to have powerful benefits, but the potential for overdose makes it unlikely to be allowed for public use. BioPharm have developed similar products with a ceiling level of effect to prevent overdose.
Ketamine is a popular surgical anaesthetic found to have mental health benefits, such as relief of treatment resistant depression, but is toxic to bladder. BioPharm team have worked on a number of improvements to this molecule.
MDMA is fast becoming a popular medicine for a variety of symptoms, but is toxic to heart and brain. BioPharm's EASE project has safer alternatives under development.
Stimulants such as cocaine and methamphetamine are widely used in the community but can have devastating consequences. Developing substitution drugs with less risk is becoming an attractive policy solution and we are working on the technology to get there.
Powered by WhatsApp Chat
